...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Recent Funding - Zenith CC
Reply New Message
Prev Message Back To Forum Threaded View Next Message

1) Exempt Distribution September 27, 2022, 1.5 mil shares @ $1.37 = $2,055,000.00

with 1/2 warrants Nov 14, 2023 @ $1.37

2) October 12, 2022, Promissory Note $350,000.00 (posted previously)

with 150,000 warrants, November 12, 2027 @ $0.75

3) Exempt Distribution October 18, 2022, 56,985 shares @ $1.03 = $58,695.00

with warrants October 18, 2024

All funds are Canadian. Total $2,463,695.00

ZHCLF shares are trading at $0.16 US ( $0.21 CAN)

 

Koo

 

 

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply